Personalized statin therapy: Targeting metabolic processes to modulate the therapeutic and adverse effects of statins
Open Access
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (32171167)
This publication has 242 references indexed in Scilit:
- Up‐regulation of miR‐let7a‐5p Leads to Decreased Expression of ABCC2 in Obstructive CholestasisHepatology Communications, 2019
- Spectrum of statin hepatotoxicity: Experience of the drug-induced liver injury networkHepatology, 2014
- Quantitative assessment of the contribution of sodium‐dependent taurocholate co‐transporting polypeptide (NTCP) to the hepatic uptake of rosuvastatin, pitavastatin and fluvastatinBiopharmaceutics & Drug Disposition, 2013
- Aryl hydrocarbon receptor regulates the cholesterol biosynthetic pathway in a dioxin response element-independent mannerHepatology, 2012
- Aryl-hydrocarbon receptor activation regulates constitutive androstane receptor levels in murine and human liverHepatology, 2007
- Statin-Associated MyopathyJAMA, 2003
- Pitavastatin Enhanced BMP-2 and Osteocalcin Expression by Inhibition of Rho-Associated Kinase in Human OsteoblastsBiochemical and Biophysical Research Communications, 2001
- HMG CoA Reductase Inhibitor-Induced Myotoxicity: Pravastatin and Lovastatin Inhibit the Geranylgeranylation of Low-Molecular-Weight Proteins in Neonatal Rat Muscle Cell CultureToxicology and Applied Pharmacology, 1997
- Inhibition of Cholesterol Synthesis by Squalene Synthase Inhibitors Does Not Induce Myotoxicityin VitroToxicology and Applied Pharmacology, 1997
- Pharmacokinetics of Fluvastatin After Single and Multiple Doses in Normal VolunteersThe Journal of Clinical Pharmacology, 1992